You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 156 No. 19, 28 OCTOBER 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  REVIEW ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Clinical Implications of Barrett's Esophagus

Gary W. Crooks, MD; Gary R. Lichtenstein, MD

Arch Intern Med. 1996;156(19):2174-2180.


Abstract

Barrett's esophagus is a medical condition in which the squamous mucosa that normally lines the distal esophagus is replaced by a columnar type of epithelium. Most definitions that have been used for inclusion of patients in studies have indicated that columnar mucosa must extend 3 cm or more above the gastroesophageal junction. The precise length refers to the distance above the manometrically defined lower esophageal sphincter. This measurement is somewhat cumbersome to make on a routine basis for all patients at the time of endoscopy and thus is generally not done. It is important to realize that the gastroesophageal junction can be visually identified at the area where the esophagus tapers, in the region of the lower esophageal sphincter. The tapering of the esophagus in the region of the lower esophageal sphincter may be difficult to determine when lower esophageal sphincter pressures are low; thus, we commonly say that Barrett's esophagus is defined as columnar mucosa 3 cm above the region where the gastric folds end.



Author Affiliations

From the Department of Medicine, University of Pennsylvania Medical Center and University of Pennsylvania School of Medicine, Philadelphia.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Screening and Barrett's Esophagus
Langdon
Arch Intern Med 1997;157:1139-1139.
ABSTRACT  

Inhibiting Acid Production Does Not Lead to Reversion of Barrett's Esophagus
Bozymski
Arch Intern Med 1997;157:1043-1043.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.